05:34:04 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Umbral Energy Corp
Symbol UMB
Shares Issued 131,491,972
Close 2017-09-01 C$ 0.125
Market Cap C$ 16,436,497
Recent Sedar Documents

Umbral completes early close on Falkland property

2017-09-05 11:01 ET - News Release

Mr. Jagdip Bal reports

UMBRAL COMPLETES EARLY CLOSE ON FALKLAND FACILITY

Umbral Energy Corp. has completed the final payment one month early on the purchase of the Falkland, B.C., property, as previously announced on May 10, 2017. The final payment of $895,000 plus closing costs was completed Aug. 31, 2017, and the company now has full access to the property.

The Falkland facility will be used by Umbral's 75-per-cent-owned subsidiary PhyeinMed Inc., a late-stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations). The entire facility consists of 13 acres of land and includes 10,500 square feet of potential grow area, plus areas identified for a sizable vault, laboratory, drying room, nursery and office area for a total of 15,500 square feet of facility. Engineering and architectural plans and drawings are already under way, and the company will update shareholders as the buildout progresses.

Clint Sharples, chairman of Umbral, stated: "The closing of the property transaction one month early is a testament to the hard work and efforts by Jag Bal and Debra Senger, and their respective teams at Umbral and PhyeinMed. I am proud of our combined group's ability to follow through on commitments, and I look forward to watching the continued progression toward our ultimate goal of achieving an ACMPR licence from Health Canada."

PhyeinMed has contracted and has been working with a general contractor, architect and engineering firms to oversee the construction of the project for the past few months. First review of blueprints to tender the project for construction quotes are expected early this week.

Recent rule changes by Health Canada has led to new and creative ways to maximize revenues per square foot, and the professionals that PhyeinMed is working with have previous experience with building pharmaceutical, hospital and ACMPR-licensed producer facilities.

"Choosing the right partners was an extremely important process for us," commented Debra Senger, chief executive officer of PhyeinMed. "We are very comfortable with the experience of the companies and the people we have contracted to work with on this project, and we are all focused on completing our buildout on time and on budget."

About Umbral Energy Corp.

The company is currently listed as a junior resource issuer having mineral exploration projects in Quebec. Additionally, in efforts to increase shareholder value, the company is also involved in other activities, including a non-resource project. This includes the company owning a 75-per-cent interest in PhyeinMed, a Health Canada late-stage applicant under the ACMPR.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.